Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-02-19

FDA Approved: CARBAMAZEPINE — Supplemental Application (Torrent Pharmaceuticals Limited)

View source ↗

Summary

The FDA approved Torrent Pharmaceuticals Limited's supplemental application for carbamazepine, a generic anticonvulsant.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Carbamazepine (Carbamazepine)

Snippet

SUPPL AP for CARBAMAZEPINE (CARBAMAZEPINE)